(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SELENBP1 mRNA] CTD PMID:31150632 (-)-alpha-phellandrene increases expression ISO RGD:733754 6480464 alpha phellandrene results in increased expression of SELENBP1 mRNA, alpha phellandrene results in increased expression of SELENBP2 mRNA CTD PMID:25075043 (1->4)-beta-D-glucan multiple interactions ISO RGD:1552441 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SELENBP1 mRNA CTD PMID:36331819 1,1-dichloroethene decreases expression ISO RGD:1552441 6480464 vinylidene chloride results in decreased expression of SELENBP1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:1552441 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SELENBP1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:1552441 6480464 Ethinyl Estradiol results in increased expression of SELENBP1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:1552441 6480464 Ethinyl Estradiol affects the expression of SELENBP1 mRNA CTD PMID:17555576 17beta-estradiol decreases expression ISO RGD:733754 6480464 Estradiol results in decreased expression of SELENBP1 mRNA CTD PMID:15159206 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of SELENBP1 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions ISO RGD:733754 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SELENBP1 mRNA CTD PMID:30165855 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one decreases expression ISO RGD:733754 6480464 Metribolone results in decreased expression of SELENBP1 protein CTD PMID:17152098 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:733754 6480464 Dihydrotestosterone results in increased expression of SELENBP1 mRNA CTD PMID:16631469 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733754 6480464 Tetrachlorodibenzodioxin results in decreased expression of SELENBP1 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SELENBP1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1552441 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of SELENBP1 mRNA, [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SELENBP1 mRNA CTD PMID:16214954 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552441 6480464 Tetrachlorodibenzodioxin affects the expression of SELENBP1 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1552441 6480464 Tetrachlorodibenzodioxin results in increased expression of SELENBP1 mRNA CTD PMID:17035482 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733754 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SELENBP1 mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SELENBP1 mRNA, Tetrachlorodibenzodioxin results in increased expression of SELENBP1 protein CTD PMID:19492234 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SELENBP1 mRNA CTD PMID:22298810 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of SELENBP1 mRNA CTD PMID:21346803 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SELENBP1 mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of SELENBP1 mRNA CTD PMID:17109745 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SELENBP1 mRNA CTD PMID:28522335 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin analog results in decreased expression of SELENBP1 protein CTD PMID:26597043 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733754 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of SELENBP1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:733754 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SELENBP1 protein CTD PMID:34186270 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of SELENBP1 mRNA CTD PMID:21346803 4-hydroxynon-2-enal decreases expression ISO RGD:733754 6480464 4-hydroxy-2-nonenal results in decreased expression of SELENBP1 mRNA CTD PMID:12419474 4-nitrophenol increases expression ISO RGD:1552441 6480464 4-nitrophenol results in increased expression of SELENBP1 mRNA CTD PMID:34673133 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SELENBP1 mRNA CTD PMID:30047161 acrolein multiple interactions ISO RGD:733754 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SELENBP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SELENBP1 mRNA CTD PMID:32699268 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SELENBP1 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:733754 6480464 Acrylamide results in decreased expression of SELENBP1 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:733754 6480464 Aflatoxin B1 affects the expression of SELENBP1 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:1552441 6480464 Aflatoxin B1 results in decreased expression of SELENBP1 mRNA CTD PMID:19770486 aflatoxin B1 decreases expression ISO RGD:733754 6480464 Aflatoxin B1 results in decreased expression of SELENBP1 mRNA CTD PMID:27153756 , PMID:32234424 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of SELENBP1 mRNA CTD PMID:17109745 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of SELENBP1 mRNA CTD PMID:20488242 alpha-phellandrene increases expression ISO RGD:733754 6480464 alpha phellandrene results in increased expression of SELENBP1 mRNA, alpha phellandrene results in increased expression of SELENBP2 mRNA CTD PMID:25075043 alpha-pinene multiple interactions ISO RGD:733754 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SELENBP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SELENBP1 mRNA CTD PMID:32699268 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of SELENBP1 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SELENBP1 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of SELENBP1 mRNA CTD PMID:30779732 aniline increases nitrosation EXP 6480464 aniline results in increased nitrosation of SELENBP1 protein CTD PMID:21708182 antirheumatic drug decreases expression ISO RGD:733754 6480464 Antirheumatic Agents results in decreased expression of SELENBP1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:733754 6480464 aristolochic acid I results in increased expression of SELENBP1 mRNA CTD PMID:33212167 benzo[a]pyrene decreases expression ISO RGD:733754 6480464 Benzo(a)pyrene results in decreased expression of SELENBP1 mRNA CTD PMID:20106945 , PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:733754 6480464 Benzo(a)pyrene results in increased methylation of SELENBP1 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:733754 6480464 Benzo(a)pyrene affects the methylation of SELENBP1 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1552441 6480464 [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of SELENBP1 mRNA] CTD PMID:14625279 benzo[a]pyrene increases expression ISO RGD:1552441 6480464 Benzo(a)pyrene results in increased expression of SELENBP1 mRNA CTD PMID:14625279 more ... Benzo[k]fluoranthene increases expression ISO RGD:1552441 6480464 benzo(k)fluoranthene results in increased expression of SELENBP1 mRNA CTD PMID:26377693 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of SELENBP1 mRNA CTD PMID:17109745 bilirubin IXalpha decreases expression ISO RGD:733754 6480464 Bilirubin results in decreased expression of SELENBP1 mRNA CTD PMID:20196124 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:733754 6480464 Diethylhexyl Phthalate results in decreased expression of SELENBP1 mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:733754 6480464 bisphenol A results in decreased expression of SELENBP1 mRNA, bisphenol A results in decreased expression of SELENBP1 protein CTD PMID:15159206 , PMID:31675489 bisphenol A affects expression ISO RGD:733754 6480464 bisphenol A affects the expression of SELENBP1 protein CTD PMID:34186270 bisphenol A increases expression ISO RGD:1552441 6480464 bisphenol A results in increased expression of SELENBP1 mRNA CTD PMID:33221593 bisphenol A increases expression ISO RGD:733754 6480464 bisphenol A results in increased expression of SELENBP1 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SELENBP1 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SELENBP1 mRNA, bisphenol A results in decreased expression of SELENBP1 protein CTD PMID:22649256 , PMID:32145629 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SELENBP1 mRNA CTD PMID:25181051 , PMID:30903817 Bisphenol B increases expression ISO RGD:733754 6480464 bisphenol B results in increased expression of SELENBP1 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:733754 6480464 bisphenol F results in increased expression of SELENBP1 protein CTD PMID:34186270 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of SELENBP1 protein CTD PMID:25933445 bromobenzene affects binding EXP 6480464 bromobenzene metabolite binds to SELENBP1 protein CTD PMID:17305373 buta-1,3-diene increases expression ISO RGD:1552441 6480464 1, 3-butadiene results in increased expression of SELENBP1 mRNA CTD PMID:29038090 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of SELENBP1 mRNA CTD PMID:19167457 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of SELENBP1 protein CTD PMID:25343288 cadmium atom multiple interactions ISO RGD:733754 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SELENBP1 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:733754 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SELENBP1 mRNA CTD PMID:35301059 cadmium sulfate increases expression ISO RGD:1552441 6480464 cadmium sulfate results in increased expression of SELENBP1 mRNA CTD PMID:19274763 carbon nanotube decreases expression ISO RGD:1552441 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carbon nanotube multiple interactions ISO RGD:1552441 6480464 [Nanotubes more ... CTD PMID:28807745 chlordecone decreases expression ISO RGD:1552441 6480464 Chlordecone results in decreased expression of SELENBP1 protein CTD PMID:19666090 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of SELENBP1 mRNA CTD PMID:30744511 chloroprene increases expression ISO RGD:1552441 6480464 Chloroprene results in increased expression of SELENBP1 mRNA CTD PMID:23125180 ciguatoxin CTX1B affects expression ISO RGD:1552441 6480464 Ciguatoxins affects the expression of SELENBP1 mRNA CTD PMID:18353800 clobetasol increases expression ISO RGD:1552441 6480464 Clobetasol results in increased expression of SELENBP1 mRNA CTD PMID:27462272 clofibrate decreases expression ISO RGD:1552441 6480464 Clofibrate results in decreased expression of SELENBP1 mRNA CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:733754 6480464 cobaltous chloride results in decreased expression of SELENBP1 mRNA CTD PMID:19376846 copper atom affects abundance ISO RGD:733754 6480464 SELENBP1 gene SNP affects the abundance of Copper CTD PMID:23720494 copper(0) affects abundance ISO RGD:733754 6480464 SELENBP1 gene SNP affects the abundance of Copper CTD PMID:23720494 coumestrol multiple interactions ISO RGD:733754 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of SELENBP1 mRNA CTD PMID:19167446 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SELENBP1 mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO RGD:733754 6480464 Cyclosporine results in decreased expression of SELENBP1 mRNA CTD PMID:20106945 more ... D-penicillamine decreases expression EXP 6480464 Penicillamine results in decreased expression of SELENBP1 mRNA CTD PMID:19575532 dexamethasone increases expression ISO RGD:733754 6480464 Dexamethasone results in increased expression of SELENBP1 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:733754 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of SELENBP1 mRNA CTD PMID:28628672 dibenzofurans increases expression ISO RGD:1552441 6480464 Dibenzofurans results in increased expression of SELENBP1 mRNA CTD PMID:34254344 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SELENBP1 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression ISO RGD:1552441 6480464 Dibutyl Phthalate results in decreased expression of SELENBP1 mRNA CTD PMID:21266533 diethylstilbestrol decreases expression ISO RGD:733754 6480464 Diethylstilbestrol results in decreased expression of SELENBP1 mRNA CTD PMID:15159206 dimethyl sulfoxide increases abundance ISO RGD:733754 6480464 SELENBP1 gene mutant form results in increased abundance of Dimethyl Sulfoxide CTD PMID:29255262 dioxygen increases expression ISO RGD:1552441 6480464 Oxygen deficiency results in increased expression of SELENBP1 mRNA CTD PMID:17193925 , PMID:20880076 dioxygen multiple interactions ISO RGD:1552441 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SELENBP1 mRNA CTD PMID:30529165 diuron decreases expression EXP 6480464 Diuron results in decreased expression of SELENBP1 mRNA CTD PMID:25152437 diuron increases expression EXP 6480464 Diuron results in increased expression of SELENBP1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:733754 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SELENBP1 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:733754 6480464 Doxorubicin results in decreased expression of SELENBP1 mRNA CTD PMID:29803840 elemental selenium increases expression ISO RGD:733754 6480464 Selenium results in increased expression of SELENBP1 mRNA, Selenium results in increased expression of SELENBP1 protein CTD PMID:16380993 endosulfan multiple interactions ISO RGD:733754 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SELENBP1 mRNA CTD PMID:26159488 entinostat increases expression ISO RGD:733754 6480464 entinostat results in increased expression of SELENBP1 mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:733754 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SELENBP1 protein CTD PMID:23301498 epoxiconazole decreases expression ISO RGD:1552441 6480464 epoxiconazole results in decreased expression of SELENBP1 mRNA CTD PMID:35436446 erlotinib hydrochloride decreases expression ISO RGD:733754 6480464 Erlotinib Hydrochloride results in decreased expression of SELENBP1 mRNA CTD PMID:27720938 estriol decreases expression ISO RGD:733754 6480464 Estriol results in decreased expression of SELENBP1 mRNA CTD PMID:15159206 estrone decreases expression ISO RGD:733754 6480464 Estrone results in decreased expression of SELENBP1 mRNA CTD PMID:15159206 flutamide increases expression EXP 6480464 Flutamide results in increased expression of SELENBP1 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SELENBP1 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:1552441 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SELENBP1 mRNA CTD PMID:22206623 genistein decreases expression ISO RGD:733754 6480464 Genistein results in decreased expression of SELENBP1 mRNA CTD PMID:15159206 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SELENBP1 mRNA CTD PMID:20623750 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of SELENBP1 mRNA CTD PMID:24136188 glyphosate increases expression ISO RGD:1552441 6480464 glyphosate results in increased expression of SELENBP1 protein CTD PMID:37208198 indometacin multiple interactions ISO RGD:733754 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of SELENBP1 mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:1552441 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SELENBP1 mRNA CTD PMID:36331819 isoflavones increases expression ISO RGD:733754 6480464 Isoflavones results in increased expression of SELENBP1 mRNA CTD PMID:17374662 ivermectin decreases expression ISO RGD:733754 6480464 Ivermectin results in decreased expression of SELENBP1 protein CTD PMID:32959892 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of SELENBP1 mRNA CTD PMID:24136188 lipopolysaccharide decreases expression ISO RGD:1552441 6480464 Lipopolysaccharides results in decreased expression of SELENBP1 mRNA CTD PMID:19136613 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of SELENBP1 mRNA CTD PMID:28801915 methanethiol increases metabolic processing ISO RGD:733754 6480464 SELENBP1 protein results in increased metabolism of methylmercaptan CTD PMID:29255262 methanethiol decreases metabolic processing ISO RGD:1552441 6480464 SELENBP1 gene mutant form results in decreased metabolism of methylmercaptan CTD PMID:29255262 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SELENBP1 mRNA CTD PMID:30467583 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of SELENBP1 mRNA CTD PMID:30047161 methoxychlor decreases expression ISO RGD:733754 6480464 Methoxychlor results in decreased expression of SELENBP1 mRNA CTD PMID:15159206 methylmercury chloride decreases expression ISO RGD:733754 6480464 methylmercuric chloride results in decreased expression of SELENBP1 mRNA CTD PMID:28001369 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of SELENBP1 mRNA CTD PMID:30744511 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:1552441 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of SELENBP1 mRNA CTD PMID:25566086 N-Nitrosopyrrolidine decreases expression ISO RGD:733754 6480464 N-Nitrosopyrrolidine results in decreased expression of SELENBP1 mRNA CTD PMID:32234424 naphthalene multiple interactions ISO RGD:1552441 6480464 [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of SELENBP1 protein CTD PMID:19438287 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of SELENBP1 mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:733754 6480464 Nickel results in decreased expression of SELENBP1 mRNA CTD PMID:24768652 , PMID:25583101 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of SELENBP1 mRNA CTD PMID:33484710 Nonylphenol decreases expression ISO RGD:733754 6480464 nonylphenol results in decreased expression of SELENBP1 mRNA CTD PMID:15159206 O-methyleugenol decreases expression ISO RGD:733754 6480464 methyleugenol results in decreased expression of SELENBP1 mRNA CTD PMID:32234424 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SELENBP1 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SELENBP1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:733754 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SELENBP1 mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO RGD:1552441 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SELENBP1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SELENBP1 mRNA CTD PMID:34911549 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of SELENBP1 mRNA CTD PMID:27638505 paracetamol decreases expression ISO RGD:733754 6480464 Acetaminophen results in decreased expression of SELENBP1 mRNA CTD PMID:29067470 paracetamol affects expression ISO RGD:1552441 6480464 Acetaminophen affects the expression of SELENBP1 mRNA CTD PMID:15606129 perfluorononanoic acid decreases expression ISO RGD:733754 6480464 perfluoro-n-nonanoic acid results in decreased expression of SELENBP1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1552441 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SELENBP1 mRNA more ... CTD PMID:36331819 phenethyl isothiocyanate decreases expression EXP 6480464 phenethyl isothiocyanate results in decreased expression of SELENBP1 mRNA CTD PMID:17616710 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of SELENBP1 mRNA CTD PMID:18158353 phenylmercury acetate decreases expression ISO RGD:733754 6480464 Phenylmercuric Acetate results in decreased expression of SELENBP1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733754 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SELENBP1 mRNA CTD PMID:27188386 potassium chromate multiple interactions ISO RGD:1552441 6480464 [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of SELENBP1 mRNA] CTD PMID:14625279 potassium dichromate multiple interactions ISO RGD:1552441 6480464 [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of SELENBP1 mRNA] CTD PMID:14625279 progesterone affects expression ISO RGD:1552441 6480464 Progesterone affects the expression of SELENBP1 mRNA CTD PMID:17251523 propiconazole increases metabolic processing ISO RGD:1552441 6480464 propiconazole results in increased metabolism of SELENBP1 protein CTD PMID:19714882 quercetin affects expression EXP 6480464 Quercetin affects the expression of SELENBP1 mRNA CTD PMID:18178720 quercetin decreases expression ISO RGD:733754 6480464 Quercetin results in decreased expression of SELENBP1 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:733754 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of SELENBP1 mRNA CTD PMID:19167446 SB 431542 multiple interactions ISO RGD:733754 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SELENBP1 mRNA CTD PMID:27188386 selenium atom increases expression ISO RGD:733754 6480464 Selenium results in increased expression of SELENBP1 mRNA, Selenium results in increased expression of SELENBP1 protein CTD PMID:16380993 silicon dioxide decreases expression ISO RGD:733754 6480464 Silicon Dioxide analog results in decreased expression of SELENBP1 mRNA, Silicon Dioxide results in decreased expression of SELENBP1 mRNA CTD PMID:25895662 , PMID:28425640 sodium arsenite decreases expression ISO RGD:733754 6480464 sodium arsenite results in decreased expression of SELENBP1 mRNA, sodium arsenite results in decreased expression of SELENBP1 protein CTD PMID:24866292 , PMID:29301061 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of SELENBP1 protein CTD PMID:29459688 Soman decreases expression EXP 6480464 Soman results in decreased expression of SELENBP1 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:1552441 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SELENBP1 mRNA CTD PMID:21641980 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of SELENBP1 mRNA CTD PMID:30047161 sulforaphane decreases expression ISO RGD:733754 6480464 sulforaphane results in decreased expression of SELENBP1 mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:733754 6480464 Sunitinib results in decreased expression of SELENBP1 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1552441 6480464 Tamoxifen affects the expression of SELENBP1 mRNA CTD PMID:17555576 tanespimycin multiple interactions ISO RGD:733754 6480464 [tanespimycin co-treated with VER 155008] results in decreased expression of SELENBP1 protein CTD PMID:31370342 temozolomide increases expression ISO RGD:733754 6480464 Temozolomide results in increased expression of SELENBP1 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:733754 6480464 tert-Butylhydroperoxide results in decreased expression of SELENBP1 mRNA CTD PMID:12419474 tert-butyl hydroperoxide increases expression ISO RGD:1552441 6480464 tert-Butylhydroperoxide results in increased expression of SELENBP1 mRNA CTD PMID:15003993 tetrachloromethane decreases expression ISO RGD:1552441 6480464 Carbon Tetrachloride results in decreased expression of SELENBP1 mRNA, Carbon Tetrachloride results in decreased expression of SELENBP1 protein CTD PMID:17109383 more ... tetrachloromethane affects expression ISO RGD:1552441 6480464 Carbon Tetrachloride affects the expression of SELENBP1 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SELENBP1 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SELENBP1 mRNA CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SELENBP1 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SELENBP1 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of SELENBP1 mRNA CTD PMID:25729387 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of SELENBP1 gene CTD PMID:27618143 trimellitic anhydride decreases expression ISO RGD:1552441 6480464 trimellitic anhydride results in decreased expression of SELENBP1 mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1552441 6480464 Troglitazone results in decreased expression of SELENBP1 mRNA CTD PMID:12732648 trovafloxacin decreases expression ISO RGD:1552441 6480464 trovafloxacin results in decreased expression of SELENBP1 mRNA CTD PMID:35537566 valproic acid decreases expression ISO RGD:733754 6480464 Valproic Acid results in decreased expression of SELENBP1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:733754 6480464 Valproic Acid affects the expression of SELENBP1 mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:733754 6480464 Valproic Acid results in increased methylation of SELENBP1 gene CTD PMID:29154799 vancomycin increases expression ISO RGD:1552441 6480464 Vancomycin results in increased expression of SELENBP1 mRNA CTD PMID:18930951 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SELENBP1 mRNA CTD PMID:22570695 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of SELENBP1 mRNA CTD PMID:19015723 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of SELENBP1 mRNA CTD PMID:16140947 zinc atom multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in decreased expression of SELENBP1 mRNA] CTD PMID:16140947 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of SELENBP1 mRNA CTD PMID:16140947 zinc(0) multiple interactions EXP 6480464 Zinc inhibits the reaction [Zinc deficiency results in decreased expression of SELENBP1 mRNA] CTD PMID:16140947